相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cerebral basis of visual hallucinations in Parkinson's disease: Structural and functional MRI studies
Naroa Ibarretxe-Bilbao et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Racial Differences May Influence the Role of Cholecystokinin Polymorphisms in Parkinson's Disease Hallucinations
Jennifer G. Goldman et al.
MOVEMENT DISORDERS (2011)
Genotype and Ancestry Modulate Brain's DAT Availability in Healthy Humans
Elena Shumay et al.
PLOS ONE (2011)
A 12-Year Population-Based Study of Psychosis in Parkinson Disease
Elin B. Forsaa et al.
ARCHIVES OF NEUROLOGY (2010)
Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD
Veronica Contini et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Epidemiology of psychosis in Parkinson's disease
Gilles Fenelon et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia
Mingqing Xu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder
Xiaohui Xu et al.
BMC PSYCHIATRY (2009)
Dopamine Transporter Genetic Variants and Pesticides in Parkinson's Disease
Beate R. Ritz et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2009)
A Common Haplotype at the Dopamine Transporter Gene 5′ Region is Associated With Attention-Deficit/Hyperactivity Disorder
Julia P. Genro et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)
Genetic Heterogeneity in ADHD: DAT1 Gene Only Affects Probands Without CD
Kaixin Zhou et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)
The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease
Sebastian Paus et al.
MOVEMENT DISORDERS (2008)
Risk factors for somnolence, edema, and hallucinations in early Parkinson disease
Kevin M. Biglan et al.
NEUROLOGY (2007)
A promoter polymorphism (-839 C>T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children
Julia P. Genro et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Clinical phenotype of Parkinson disease dementia
James E. Galvin et al.
NEUROLOGY (2006)
The malignant course of benign hallucinations in Parkinson disease
CG Goetz et al.
ARCHIVES OF NEUROLOGY (2006)
Benign tremulous Parkinsonism
KA Josephs et al.
ARCHIVES OF NEUROLOGY (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
Dopamine transporter (SLC6A3) 5′ region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease
SN Kelada et al.
PHARMACOGENETICS AND GENOMICS (2005)
Dopamine transporter gene polymorphism, SPECT imaging, and levodopa response in patients with Parkinson disease
M Contin et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom
P Hobson et al.
MOVEMENT DISORDERS (2004)
Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies
S Greenland
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Genetic polymorphisms subjects in Parkinson disease subjects with or without hallucinations - An analysis of the cholecystokinin system
JG Goldman et al.
ARCHIVES OF NEUROLOGY (2004)
L-Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism
R Kaiser et al.
NEUROLOGY (2003)
Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease
J Wang et al.
PHARMACOGENETICS (2003)
The homozygote 10-copy genotype of variable number tandem repeat dopamine transporter gene may confer protection against Parkinson's disease for male, but not to female patients
JJ Lin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene
TA Greenwood et al.
GENOMICS (2003)
Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease - A survey by the Canadian Movement Disorders Group
DE Hobson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Prospective longitudinal assessment of hallucinations in Parkinson's disease
CG Goetz et al.
NEUROLOGY (2001)
Attention-deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene
T Roman et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2001)
The human dopamine transporter gene:: the 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample
C Rubie et al.
NEUROSCIENCE LETTERS (2001)
Predictors of nursing home placement in Parkinson's disease: A population-based, prospective study
D Aarsland et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2000)
Macular microcirculation characteristics in Parkinson's disease evaluated by OCT-Angiography: a literature review
Evita Evangelia Christou et al.
SEMINARS IN OPHTHALMOLOGY
分享论文
